RU92007801A - METHOD OF TREATMENT OF PINK UGRAI - Google Patents
METHOD OF TREATMENT OF PINK UGRAIInfo
- Publication number
- RU92007801A RU92007801A RU92007801/14A RU92007801A RU92007801A RU 92007801 A RU92007801 A RU 92007801A RU 92007801/14 A RU92007801/14 A RU 92007801/14A RU 92007801 A RU92007801 A RU 92007801A RU 92007801 A RU92007801 A RU 92007801A
- Authority
- RU
- Russia
- Prior art keywords
- treatment
- patients
- pink
- therapeutic effect
- solution
- Prior art date
Links
- 102000019197 Superoxide Dismutase Human genes 0.000 claims 2
- 108010012715 Superoxide Dismutase Proteins 0.000 claims 2
- 230000003078 antioxidant Effects 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 235000006708 antioxidants Nutrition 0.000 claims 2
- 201000004700 rosacea Diseases 0.000 claims 2
- 230000001225 therapeutic Effects 0.000 claims 2
- 206010000496 Acne Diseases 0.000 claims 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims 1
- 241001303601 Rosacea Species 0.000 claims 1
- 210000002966 Serum Anatomy 0.000 claims 1
- 210000003491 Skin Anatomy 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 229960001452 alpha-Tocopherol Acetate Drugs 0.000 claims 1
- 230000024881 catalytic activity Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000002085 persistent Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 231100000486 side effect Toxicity 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU92007801A RU2098091C1 (en) | 1992-11-24 | 1992-11-24 | Method of pink acne treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU92007801A RU2098091C1 (en) | 1992-11-24 | 1992-11-24 | Method of pink acne treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
RU92007801A true RU92007801A (en) | 1995-02-10 |
RU2098091C1 RU2098091C1 (en) | 1997-12-10 |
Family
ID=20132486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU92007801A RU2098091C1 (en) | 1992-11-24 | 1992-11-24 | Method of pink acne treatment |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2098091C1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2645932C1 (en) * | 2017-02-15 | 2018-02-28 | Ольга Юрьевна Олисова | Method of complex extrinsic for patients with erithematous papular rosacea |
-
1992
- 1992-11-24 RU RU92007801A patent/RU2098091C1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Falanga et al. | Topical use of human recombinant epidermal growth factor (h‐EGF) in venous ulcers | |
Yosipovitch, M Widijanti Sugeng, A Goon, YH Chan, CL Goh | A comparison of the combined effect of cryotherapy and corticosteroid injections versus corticosteroids and cryotherapy alone on keloids: a controlled study | |
PL340096A1 (en) | Methods of treating hypercoagulability states or hypoproteinaemia in respect to c protein | |
US6242010B1 (en) | Synergistic antioxidant compositions in management of hemorrhoids and other ano-rectal inflammatory conditions | |
JPH0859463A (en) | Preparation and medicine containing coumarin and their use in beauty field | |
DE69722401D1 (en) | COMBINATIONS OF VASOPRESSIN AND ADRENERGIC ACTIVE SUBSTANCES FOR TREATING SUDDEN HEART DEATH | |
WO1991004058A3 (en) | Treatment of conditions and disease | |
JPH06500708A (en) | Improved iontophoretic administration of drugs | |
Matsuda et al. | Antioxidant therapy using high dose vitamin C: reduction of postburn resuscitation fluid volume requirements | |
US8343486B2 (en) | Methods and compositions for topical treatment of medical conditions including wounds and inflammation | |
Zhang et al. | Positive effects of low‐dose photodynamic therapy with aminolevulinic acid or its methyl ester in skin rejuvenation and wound healing: An update | |
FRY et al. | EFFECT OF EETINOIC ACID IN PSORIASIS | |
Ashcroft | Recognizing and treating venous stasis ulcers | |
RU92007801A (en) | METHOD OF TREATMENT OF PINK UGRAI | |
Cerchiari et al. | Effects of combined superoxide dismutase and deferoxamine on recovery of brainstem auditory evoked potentials and EEG after asphyxial cardiac arrest in dogs | |
KR20180070708A (en) | Plasminogen therapy for wound healing | |
Goldfarb et al. | Topical tretinoin and photoaged skin | |
CA2100314C (en) | Pharmaceutical composition for the treatment of chronic skin ulcers | |
SU1117056A1 (en) | Method of lowering the level of chlorestirin and @-lipoproteins in peripheric blood of patients ill with atherosclerosis | |
BLANK | What are the functions of skin lost in burn injury that affect short-and long-term recovery? | |
Butt et al. | Preparation of Antisera to Human Folliclestimulating Hormone | |
Angelides et al. | Effect of pentoxifylline on treatment of lower limb ulcers in patients with thalassemia major | |
RU94004116A (en) | METHOD OF TREATMENT OF PINK UGRAI | |
RU2084230C1 (en) | Method of psoriasis treatment | |
Harth et al. | A case of basal cell carcinoma treated with photodynamic therapy—changes in histological features and bcl-2 expression |